Chinese Academy of Medical Sciences
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT03199677
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Hospital Based Survey on Lung Cancer Related-pain in Northern China
- Conditions
- Lung CancerCancer Pain
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 2000
- Registration Number
- NCT03189277
A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients
Not Applicable
- Conditions
- Supraglottic Airway
- Interventions
- Device: Ambu AuraGainDevice: LMA Supreme
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT03108391
- Locations
- 🇨🇳
ChineseAMS, Beijing, Beijing, China
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2
Completed
- Conditions
- Gastric CancerGastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2017-03-20
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 41
- Registration Number
- NCT03083613
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Beijing, China
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
- Conditions
- Advanced Breast Cancer
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 4200
- Registration Number
- NCT03047889
- Locations
- 🇨🇳
The First Hospital of Xi'an Jiaotong University, Xi'an, China
🇨🇳FuZhou General Hospital of National Miltary Command, Fuzhou, China
🇨🇳Sichuan Cancer Hospital and Institute, Chengdu, China
Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy
- Conditions
- Liver InjuryChemotherapeutic ToxicityMalignant Tumor
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 180
- Registration Number
- NCT03039062
- Locations
- 🇨🇳
Cancer Hospital, ChineseAMS, Beijing, Beijing, China
Tomotherapy for Refractory Brain Metastases
Not Applicable
- Conditions
- Brain Metastases
- Interventions
- Radiation: tomotherapy
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2017-01-23
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 150
- Registration Number
- NCT03027544
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Beijing, Beijing, China
The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)
Phase 4
- Conditions
- Immunization of Inactivated EV71 VaccineSafety of Inactivated EV71 Vaccine
- Interventions
- Biological: inactivated EV71 vaccine (KMB-17)
- First Posted Date
- 2016-12-21
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 20770
- Registration Number
- NCT02999828
- Locations
- 🇨🇳
Chaoyang of Provincial Center for Diseases Control and Prevention in Beijing, Beijing, China
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2017-09-07
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 25
- Registration Number
- NCT02995187
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Beijing, China
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
Phase 2
Completed
- Conditions
- Rectal Neoplasms Malignant
- Interventions
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 68
- Registration Number
- NCT02992886
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath